Skip to content

Adverse drug events add to costs of HAART

One in five on HAART have bone problems

Twelfth International AIDS Conference

BHIVA clinicians Retroviruses roundtable feedback - Monday

Lisbon conference news: Nevirapine performs strongly in high viral load patients

Thailand to start producing own version of d4T

Hydroxyurea - when is the best time to use it?

Risk of interactions between Zyban & HAART

Taking Heart: biggest ever survey of UK HIV+ makes fascinating reading